In September 2026, StellarCube arrived at a New York meeting with a product called PainCube, an AI medical solution that measures and predicts pain from biosignals. The conversation with Elpis Labs covered valuation, competition, fundraising size, legal structure and go-to-market strategy. A clever piece of technology had brought the company to the table. Getting it into the American market required a much longer agenda.
That agenda explains Elpis Labs better than the word “matchmaking,” which makes the work sound pleasantly effortless. The company helps international startups prepare for U.S. customers and investors, while helping corporations discover technologies they might actually use. In between sit questions that resist a handsome slide deck: Who needs this? Who can approve it? What must happen before money changes hands?
- Startups get market validation, localized sales preparation and introductions.
- Corporations get technology scouting, startup evaluation and pilot support.
- Public agencies get accelerators, trade missions and softlanding programs.
The introduction is the beginning
Elpis’s corporate offering starts with a use case. Its published process includes industry research, business-case evaluation, technology matching, startup validation, pitch meetings and pilot implementation. The sequence matters. A corporation asking for “innovation” has an appetite; a corporation identifying an operational problem has something a startup can answer.
On the other side, Elpis Advisory works with post-MVP and growth-stage companies. The service includes localization, incorporation support, advisor and corporate matchmaking, pilots and investor preparation. A six-week Commercialization Sprint gives that work a defined calendar. The company also cites its team’s collective experience with more than 600 startups through Starta VC, Techstars and CUNY. That is a claim about accumulated experience, rather than a count of Elpis customers.
These two offerings meet at an awkward point in the market. A startup needs a customer willing to test something unfamiliar. A corporate team needs a credible supplier that can meet an operational requirement. Elpis’s proposition is to prepare both parties for the encounter. An introduction without that preparation would leave the most troublesome work politely waiting outside.
America is not one customer
The Korean Startup Center program offers a concrete example. Elpis’s 2025 summer event listing describes seven weeks in New York for post-revenue Korean startups, covering go-to-market strategy, intellectual property and contracts, corporate partnerships and fundraising. Ten companies appeared on the demo-day roster, from organoid developer RadaHaim to IP software provider Ipactory and logistics company Colosseum.
The variety is revealing. These businesses share a destination, but their customers, evidence requirements and sales conversations differ. Organoid technology and logistics software will not benefit from identical introductions. Elpis’s job is therefore partly one of selection: identify the particular people a particular company needs to meet.
KSC summer program
demo-day roster
Its 2025 recap reports two KSC cohorts and a Startup Biobío and Endeavor Chile delegation visiting New York and Miami. The latter explored market fit, investor pipelines, corporate opportunities and legal readiness. The useful output of a visit, on this reading, is a more accurate plan. A crowded address book is merely stationery with ambitions.
The invoice behind the itinerary
Elpis operates as a consulting and program-delivery business. Corporations, public organizations and startups engage it for different kinds of work. The public-agency relationship is especially tangible in ProChile’s 2024 Miami fintech mission, which named Elpis as a delivery partner and offered places for up to six companies.
That program specified two online preparation stages before an in-person mission on November 12-15. Sessions included market-entry planning, legal preparation, pitch coaching and fundraising materials. The schedule also provided assisted business meetings. Participation carried no fee, but companies were responsible for additional expenses. A funded program can lower the admission cost without making expansion costless.
The selection criteria are equally instructive: a dedicated team, demonstrable traction with at least five customers or beneficiaries, and evidence of revenue in the previous year. This was a program for businesses ready to investigate a market. A founder still searching for a basic use case would be arriving before the invitation applied.
A translator with several dictionaries
Anastasia Lykova Allan, Elpis’s founder and managing partner, brings a Starta VC background. Kenneth Huynh, also a managing partner, describes his work across enterprise technology, commercialization and venture investing. The official team includes venture advisors, a program director and communications specialists. Taken together, those roles suggest why the work extends beyond arranging meetings: founders need help with the business argument as well as access to the room.
The geographic range also has substance. Uzbekistan’s Youth Affairs Agency documented a June 2025 meeting with Lykova about startup support and access to markets such as New York. IT Park Uzbekistan separately reported a U.S. roundtable involving Elpis, Empire and NY Tech Alliance. These accounts establish ecosystem work and conversations; a future commercial relationship still has to be earned.
The demo ends. The buying begins.
At a September 16, 2026 session with Taiwan’s Global Innovation Hub and IAPS NYCU Accelerator, Elpis addressed roughly 40 founders and ecosystem participants. Its recap drew a distinction between technical readiness and commercial readiness, then pointed toward the corporate decision chain: business owners, budget holders, security teams, legal and procurement.
“A pilot is not the finish line. Procurement is.”
Elpis Labs · Taiwan market-entry session recap
For a founder, the transferable lesson is to investigate the buyer before making expansion expensive. For a corporate team, it is to define the problem before scouting technologies. Neither exercise guarantees a sale. Both make an introduction more useful.
Ten companies, two very specific cities
The latest Italian Trade Agency life sciences edition puts that logic on a map. Elpis describes ten Italian companies spending six weeks moving from remote sessions to San Diego and Boston, with demo days planned for November 5 and November 12, 2026. The cohort spans therapeutics, digital health and bioeconomy products, including dairy-whey skincare and products made from invasive blue crab.
The locations and sector focus give a broad promise of “U.S. access” a smaller, more workable shape. Elpis sits between the accelerator, the trade mission and the corporate innovation consultancy. Its value proposition rests on making those worlds useful to one another. PainCube’s account captures the immediate result: clearer investment, legal and business-development priorities. Before the cheque or purchase order comes a better understanding of what it would take to obtain one.